Cargando…

Patient-Reported Outcomes for Fully Vaccinated COVID-19 Patients Over 6 Weeks: The Experiences of Clinical Breakthrough Cases

BACKGROUND: While coronavirus disease 2019 (COVID-19) vaccines have high rates of efficacy, fully vaccinated individuals can become infected with COVID-19. Among this population, symptoms tend to be less severe and shorter lasting. Less is known about how vaccinated individuals who contract COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vartanian, Keri, Fish, Daniel, Gronowski, Benjamin, Kenton, Natalie, Robicsek, Ari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638265/ https://www.ncbi.nlm.nih.gov/pubmed/36336751 http://dx.doi.org/10.1007/s40271-022-00605-8

Ejemplares similares

Integrating patient-reported physical, mental, and social impacts to classify long COVID experiences
por: Vartanian, Keri, et al.
Publicado: (2023)

Participation in genetic screening: testing different outreach methods across a diverse hospital system based patient population
por: Dickey, Lindsay, et al.
Publicado: (2023)

Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression
por: Vena, Antonio, et al.
Publicado: (2022)

Risks of SARS-CoV-2 Breakthrough Infection and Hospitalization in Fully Vaccinated Patients With Multiple Myeloma
por: Wang, Lindsey, et al.
Publicado: (2021)

Evaluation of an Integrated Intervention to Address Clinical Care and Social Needs Among Patients with Type 2 Diabetes
por: Roth, Sarah E., et al.
Publicado: (2023)

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients
por: Piñana, José Luis, et al.
Publicado: (2023)

BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel
por: Brosh-Nissimov, Tal, et al.
Publicado: (2021)

P13 Risk of COVID-19 Vaccine Breakthrough Infection in Fully Vaccinated Patients with Multiple Comorbid Conditions in the United States
por: Liu, M., et al.
Publicado: (2022)

Antibody titres in fully vaccinated healthcare workers with and without breakthrough infection during the Delta and Omicron waves
por: Chandrasingh, Sindhulina, et al.
Publicado: (2023)

Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study
por: Wright, Bill J, et al.
Publicado: (2022)

SARS-CoV-2 mRNA Vaccine Breakthrough Infections in Fully Vaccinated Healthcare Personnel: A Systematic Review
por: Ledda, Caterina, et al.
Publicado: (2022)

Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker
por: Shastri, Jayanthi, et al.
Publicado: (2021)

Predictors of hospitalization and severe disease due to breakthrough SARS‐CoV‐2 infection in fully vaccinated individuals
por: Johnson, Steven, et al.
Publicado: (2022)

Breakthrough infections in MPN-COVID vaccinated patients
por: Barbui, Tiziano, et al.
Publicado: (2022)

Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnel
por: Maltezou, H.C., et al.
Publicado: (2023)

Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021
por: Vignier, Nicolas, et al.
Publicado: (2021)

Characterization of immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 delta variant
por: Collier, Ai-ris Y., et al.
Publicado: (2022)

Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
por: Stærke, Nina Breinholt, et al.
Publicado: (2022)

Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination
por: Stampfer, Samuel D., et al.
Publicado: (2022)

COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research
por: Wang, Lindsey, et al.
Publicado: (2022)

Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021
por: Wang, Lindsey, et al.
Publicado: (2021)

COVID-19 vaccination and breakthrough infections in patients with cancer
por: Schmidt, A.L., et al.
Publicado: (2022)

SARS-CoV-2 vaccination in patients with solid tumors or hematological malignancies: Is the pandemic over for fully vaccinated patients?
por: Zojer, Niklas
Publicado: (2021)

Risk of coronavirus disease 2019 (COVID-19) acquisition among emergency department patients: A retrospective case control study
por: Ridgway, Jessica P., et al.
Publicado: (2020)

Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
por: Collier, Ai-ris Y., et al.
Publicado: (2021)

Multisystem Inflammatory Syndrome in Adults or Hemophagocytic Lymphohistiocytosis: A Clinical Conundrum in Fully Vaccinated Adults With Breakthrough COVID-19 Infections
por: Narvel, Hiba, et al.
Publicado: (2022)

Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis
por: Liu, Cong, et al.
Publicado: (2022)

Clinical characteristics, outcomes, and risk factors of SARS-CoV-2 breakthrough infections among 572 fully vaccinated (BBIBP-CorV) hospitalized patients
por: Liu, Yihuang, et al.
Publicado: (2023)

VACCINATED WITH A TWIST: BREAKTHROUGH COVID-19 IN AN IMMUNOCOMPROMISED PATIENT
por: DAOUD, DANA, et al.
Publicado: (2021)

COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel
por: Yekutiel, Naama, et al.
Publicado: (2023)

Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection
por: Jeong, Hye Won, et al.
Publicado: (2022)

Emergence of Omicron BA.1 and BA.2 variants and concern over vaccine breakthrough infection
por: Sukaina, Mahnoor, et al.
Publicado: (2022)

The patent dispute over the breakthrough mRNA technology
por: Aquino-Jarquin, Guillermo
Publicado: (2022)

The latest breakthrough on NLRP6 inflammasome
por: Li, Runzhi, et al.
Publicado: (2022)

Vaccines in Breast Cancer: Challenges and Breakthroughs
por: Fatima, Gul Naz, et al.
Publicado: (2023)

Usefulness and Limitations of Anti-S IgG Assay in Detecting Previous SARS-CoV-2 Breakthrough Infection in Fully Vaccinated Healthcare Workers
por: Spiteri, Gianluca, et al.
Publicado: (2022)

A retrospective cohort study of incidence and risk factors for severe SARS-CoV-2 breakthrough infection among fully vaccinated people
por: Meister, Tatjana, et al.
Publicado: (2023)

Local Housing Choice Voucher Distribution Policies Impact Healthcare Utilization: a Randomized Natural Experiment
por: Cohen-Cline, Hannah, et al.
Publicado: (2022)

COVID-19 breakthrough infections in rheumatic diseases patients after vaccination
por: Alshukairi, Abeer N., et al.
Publicado: (2022)

Severe breakthrough COVID‐19 infections in vaccinated patients with schizophrenia in Israel
por: Tzur Bitan1,2, Dana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ja2qimqrbsivodaipttv2p63c